These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9572056)

  • 1. Molecular pathogenesis of sporadic and familial forms of Alzheimer's disease.
    Ray WJ; Ashall F; Goate AM
    Mol Med Today; 1998 Apr; 4(4):151-7. PubMed ID: 9572056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate gene association studies in sporadic Alzheimer's disease.
    Combarros O; Alvarez-Arcaya A; Sánchez-Guerra M; Infante J; Berciano J
    Dement Geriatr Cogn Disord; 2002; 14(1):41-54. PubMed ID: 12053131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of Alzheimer's disease.
    Goate AM
    Geriatrics; 1997 Sep; 52 Suppl 2():S9-12. PubMed ID: 9307578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial forms of Alzheimer's disease].
    Maréchal L; Campion D; Hannequin D
    Presse Med; 2003 May; 32(16):756-63. PubMed ID: 12856536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain.
    Lleó A; Blesa R; Queralt R; Ezquerra M; Molinuevo JL; Peña-Casanova J; Rojo A; Oliva R
    Arch Neurol; 2002 Nov; 59(11):1759-63. PubMed ID: 12433263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the etiology of Alzheimer disease using molecular genetics.
    Lendon CL; Ashall F; Goate AM
    JAMA; 1997 Mar; 277(10):825-31. PubMed ID: 9052714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of alpha1-antichymotrypsin polymorphism in familial Alzheimer's disease.
    Nacmias B; Marcon G; Tedde A; Forleo P; Latorraca S; Piacentini S; Amaducci L; Sorbi S
    Neurosci Lett; 1998 Mar; 244(2):85-8. PubMed ID: 9572591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations.
    Sudo S; Shiozawa M; Cairns NJ; Wada Y
    J Neurol Sci; 2005 Jul; 234(1-2):55-65. PubMed ID: 15946688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shutting down Alzheimer's.
    Wolfe MS
    Sci Am; 2006 May; 294(5):72-9. PubMed ID: 16708491
    [No Abstract]   [Full Text] [Related]  

  • 13. Alzheimer's disease: genotypes, phenotypes, and treatments.
    Selkoe DJ
    Science; 1997 Jan; 275(5300):630-1. PubMed ID: 9019820
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
    Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
    Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression in Alzheimer's disease.
    Ermak G; Davies KJ
    Drugs Today (Barc); 2002 Jul; 38(7):509-16. PubMed ID: 12582468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic complexity of Alzheimer's disease: successes and challenges.
    Rogaeva E; Kawarai T; George-Hyslop PS
    J Alzheimers Dis; 2006; 9(3 Suppl):381-7. PubMed ID: 16914876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the genetics of Alzheimer's disease.
    Levy-Lahad E; Tsuang D; Bird TD
    J Geriatr Psychiatry Neurol; 1998; 11(2):42-54. PubMed ID: 9877525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
    Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piecing together Alzheimer's.
    St George-Hyslop PH
    Sci Am; 2000 Dec; 283(6):76-83. PubMed ID: 11103462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.